These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32772981)

  • 1. What is the current state of patient education after
    DeBenedictus CM; Hecker MT; Zuccaro PD; John JP; Donskey CJ; Patel PK
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1338-1340. PubMed ID: 32772981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing
    Magro M; Rosenberg J; Epson E
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):292-297. PubMed ID: 32993820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Clostridioides difficile Diagnostic Stewardship Interventions on the Diagnosis of Hospital-Onset Clostridioides difficile Infections.
    Kang M; Abeles SR; El-Kareh R; Taplitz RA; Nyheim E; Reed SL; Jenkins IH; Seymann GB; Myers FE; Torriani FJ;
    Jt Comm J Qual Patient Saf; 2020 Aug; 46(8):457-463. PubMed ID: 32576438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nurses' knowledge, practices and perceptions regarding Clostridioides difficile: Survey results.
    Finnimore K; Smyth W; Carrucan J; Nagle C
    Infect Dis Health; 2023 Feb; 28(1):39-46. PubMed ID: 36002370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity in practices to reduce the risk of transmission of Clostridioides difficile in healthcare settings: a survey of ESCMID Study Group for Clostridioides difficile (ESGCD) members.
    Khanafer NL; Fitzpatrick F; Barbut F; Krutova M; Davies K; Guery B; Vanhems P
    Eur J Clin Microbiol Infect Dis; 2024 Apr; 43(4):785-789. PubMed ID: 38332395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perils and pitfalls of probiotic quasi-experimental studies for primary prevention of Clostridioides difficile infection: A review of the evidence.
    McFarland LV; Johnson SB; Evans CT
    Am J Infect Control; 2021 Mar; 49(3):375-384. PubMed ID: 32791261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the potential impact of administering vaccines against Clostridioides difficile infection to individuals in healthcare facilities.
    Toth DJA; Keegan LT; Samore MH; Khader K; O'Hagan JJ; Yu H; Quintana A; Swerdlow DL
    Vaccine; 2020 Aug; 38(37):5927-5932. PubMed ID: 32703744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospital acquired Clostridioides difficile infection and risk factors for severity in a university hospital: A prospective study.
    Bilgin H; Sayın E; Gürün HP; Tükenmez-Tigen E; Ülger Toprak N; Korten V
    Am J Infect Control; 2020 Dec; 48(12):1426-1430. PubMed ID: 32522607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of no-touch ultraviolet light room disinfection systems on Clostridioides difficile infections.
    McMullen K; Guth RM; Wood H; Mueller C; Dunn G; Wade R; Siddiqui A; Dubberke ER; Woeltje KF; Warren DK
    Am J Infect Control; 2021 May; 49(5):646-648. PubMed ID: 32860846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and infection control strategies for Clostridioides difficile infections in a setting of high antimicrobial resistance prevalence.
    Bertolino L; Patauner F; Gagliardi M; D'Amico F; Crivaro V; Bernardo M; Scherillo I; Bellitti F; Cusano C; Greco R; Panetta V; Durante A; Di Caterino A; Frieri A; Cioffi G; Nappo M; Corrado M; Lanzieri M; Sabatini P; Bettelli R; Dello Russo R; Taddeo ML; Petrone R; Di Sevo MG; Iannuzzo M; Iervolino M; Buonocore R; D'Agostino F; Gambardella M; De Martino A; Spagnuolo S; Savarese M; Sole S; Russo C; Agozzino E; Galdiero M; Martino R; Calemma R; Sciambra A; Aprea C; Colaccio D; Di Guida P; Venditti M; Montella E; Guerriero F; Perrotta R; Di Filippo U; Pizza A; Di Fronzo A; Lombardi A; Capuano L; De Stefano A; Mastropietro A; Mastro M; Loffreda R; Maccarone L; Di Tora A; Oto S; Tammaro C; Mondelli AC; Ruocco M; Ferraro B; Petrosino A; Presta SSA; Durante Mangoni E
    Infez Med; 2021 Mar; 29(1):70-78. PubMed ID: 33664175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs Associated with the Treatment of Clostridioides Difficile Infections.
    Sierocka A; Kiersnowska Z; Lemiech-Mirowska E; Marczak M
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34300098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.
    Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K
    mBio; 2020 May; 11(3):. PubMed ID: 32371595
    [No Abstract]   [Full Text] [Related]  

  • 13. A prospective, observational study of fidaxomicin use for
    Guery B; Berger P; Gauzit R; Gourdon M; Barbut F; ; Dafne Study Group ; Bémer P; Bessède E; Camou F; Cattoir V; Couzigou C; Descamps D; Dinh A; Laurans C; Lavigne JP; Lechiche C; Leflon-Guibout V; Le Monnier A; Levast M; Mootien JY; N'Guyen Y; Piroth L; Prazuck T; Rogeaux O; Roux AL; Vachée A; Vernet Garnier V; Wallet F
    J Int Med Res; 2021 Jun; 49(6):3000605211021278. PubMed ID: 34162264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks and Preventive Strategies for Clostridioides difficile Transmission to Household or Community Contacts during Transition in Healthcare Settings.
    Asgary R; Snead JA; Wahid NA; Ro V; Halim M; Stribling JC
    Emerg Infect Dis; 2021 Jul; 27(7):1776-1782. PubMed ID: 34152967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interpretation of group standard for
    Wu Y; Lu JX; Yan ZZ; Liu YX; Gu WP; Fu XQ; Xu YC; Wu AH; Huang HH; Zong ZY; Jin DZ; Zhao JH; Chen Y; Liu WP; Li WG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):64-67. PubMed ID: 33503698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and consequences of missed Clostridioides (Clostridium) difficile infection diagnosis from nonreporting of Clostridioides difficile results of the multiplex GI PCR panel: experience from two-hospitals.
    Zacharioudakis IM; Zervou FN; Phillips MS; Aguero-Rosenfeld ME
    Diagn Microbiol Infect Dis; 2021 Jun; 100(2):115346. PubMed ID: 33647544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of the Targeted Assessment for Prevention Strategy in a healthcare system to reduce
    White KA; Soe MM; Osborn A; Walling C; Fike LV; Gould CV; Kuhar DT; Edwards JR; Cochran RL
    Infect Control Hosp Epidemiol; 2020 Mar; 41(3):295-301. PubMed ID: 31928537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and treatment of Clostridioides difficile infection.
    Mateu L; Fernández-Rivas G; Sopena N
    Med Clin (Barc); 2020 Jul; 155(1):30-35. PubMed ID: 32430207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Burden of Clostridioides difficile infection (CDI) - a systematic review of the epidemiology of primary and recurrent CDI.
    Finn E; Andersson FL; Madin-Warburton M
    BMC Infect Dis; 2021 May; 21(1):456. PubMed ID: 34016040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.